This is a Randomised, Open-labeled, Multi-center Study to Investigate the Safety and Efficacy of OROS Hydromorphone HCL Comparing With Morphine SR (Sustain Release) in Cancer Pain Patients.
This study is not yet open for participant recruitment.
Study NCT00803283
Information provided by Johnson & Johnson Taiwan Ltd
First Received: December 4, 2008
Last Updated: August 27, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
